IPF Drug Deposition Study

NCT01457261 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

10

Enrollment

OTHER

Sponsor class

Conditions

Idiopathic Pulmonary Fibrosis

Interventions

DRUG: Salbutamol

Sponsor

Royal Brompton & Harefield NHS Foundation Trust

Collaborators

[object Object]